Skip to main content
Premium Trial:

Request an Annual Quote

Taiwan Research Institute Funds Isis SARS Antisense Research

NEW YORK, June 24 - Isis Pharmaceuticals is beginning a search for antisense therapies to the SARS coronavirus, which the Industrial and Technology Research Institute of Taiwan is funding with $2 million, the organizations said today.

 

Initially, the goal is to identify at least one SARS antisense drug, and then develop intravenous and aerosol forms of the drug to prepare for preclinical toxicology studies.

 

Isis, of Carlsbad, Calif., has already synthesized about 200 antisense compounds that inhibit regions of the SARS coronavirus sequences. These stretches of sequence are conserved across all known sequences of the SARS coronavirus.

 

ITRI is a non-profit research institute funded by the Taiwanese government.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.